تولید مواد اولیه داروپخش
دتماد | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/07/07 Fiscal Year 2026/03/2012 Month | 2025/05/18 Fiscal Year 2025/03/2012 Month | 2024/05/16 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 3.176 Trillion | 2.446 Trillion | 644.862 Billion | |
Trade Receivables | 21.562 Trillion | 13.335 Trillion | 9.461 Trillion | |
Prepayments | 5.765 Trillion | 2.995 Trillion | 3.282 Trillion | |
Raw Materials & Packaging Inventory | 4.516 Trillion | 4.33 Trillion | 3.313 Trillion | |
Work-in-Progress Inventory | 2.139 Trillion | 1.897 Trillion | 1.733 Trillion | |
Finished Goods Inventory | 3.875 Trillion | 3.053 Trillion | 2.024 Trillion | |
Spare Parts Inventory | 250.726 Billion | 181.815 Billion | 133.495 Billion | |
Goods in Transit | 596.817 Billion | 23.293 Billion | 95.641 Billion | |
Our Goods on Consignment with Others | 41.148 Billion | - | - | |
Other Inventories | - | 23.449 Billion | 127.428 Billion | |
Inventories | 11.419 Trillion | 9.508 Trillion | 7.427 Trillion | |
Total Current Assets | 41.922 Trillion | 28.284 Trillion | 20.814 Trillion | |
Long-Term Investments | 912 Million | 515 Million | 219 Million | |
Long-Term Trade Receivables | 58.47 Billion | 37.417 Billion | 41.621 Billion | |
Intangible Assets | 234.067 Billion | 102.504 Billion | 65.266 Billion | |
Property, Plant & Equipment | 3.188 Trillion | 11.693 Trillion | 2.103 Trillion | |
Net Fixed Assets | 3.188 Trillion | 11.693 Trillion | 2.103 Trillion | |
Total Non-Current Assets | 3.482 Trillion | 11.834 Trillion | 2.21 Trillion | |
Total Assets | 45.404 Trillion | 40.117 Trillion | 23.024 Trillion | |
Trade Payables | 6.787 Trillion | 5.229 Trillion | 2.701 Trillion | |
Advances Received | 878.152 Billion | 716.688 Billion | 1.163 Trillion | |
Income Tax Provision | 3.035 Trillion | 2.072 Trillion | 940.927 Billion | |
Proposed & Payable Dividends | 12.692 Trillion | 9.72 Trillion | 7.14 Trillion | |
Current Borrowings | 4.231 Trillion | 3.188 Trillion | 3.276 Trillion | |
Total Current Liabilities | 27.623 Trillion | 20.926 Trillion | 15.221 Trillion | |
Employee Termination Benefits Provision | 1.23 Trillion | 773.582 Billion | 579.54 Billion | |
Total Non-Current Liabilities | 1.23 Trillion | 773.582 Billion | 579.54 Billion | |
Total Liabilities | 28.854 Trillion | 21.7 Trillion | 15.801 Trillion | |
Capital | 2.8 Trillion | 715 Billion | 715 Billion | |
Retained Earnings | 13.592 Trillion | 8.937 Trillion | 6.537 Trillion | |
Legal Reserve | 280 Billion | 71.5 Billion | 71.5 Billion | |
Share Premium Reserve | -121.608 Billion | -121.608 Billion | -100.331 Billion | |
Total Equity | 16.55 Trillion | 18.418 Trillion | 7.224 Trillion | |
Total Liabilities & Equity | 45.404 Trillion | 40.117 Trillion | 23.024 Trillion | |
Approved Capital | 2.8 Trillion | 715 Billion | 715 Billion | |
Approved Retained Earnings | 5.892 Trillion | 3.431 Trillion | 2.247 Trillion | |
Approved Legal Reserve | 280 Billion | 71.5 Billion | 71.5 Billion | |
Total Approved Equity (at AGM) | 8.972 Trillion | 4.218 Trillion | 3.034 Trillion | |
Revaluation Surplus of Property, Plant and Equipment | - | 8.816 Trillion | - |